University at Buffalo Partners With Zimbabwe Universities to Create International Nanotechnology Center
September 25, 2012
Zimbabwe has a high rate (14 percent) of its population co-infected with HIV/AIDS and tuberculosis (TB), thus there is a great need for new drugs and treatments. With a view to developing new drugs to treat these diseases, the University at Buffalo's Institute for Lasers, Photonics and Biophotonics (ILPB), and the New York State Center of Excellence in Bioinformatics and Life Sciences have come together to launch the Zimbabwe International Nanotechnology Center (ZINC) a national nanotechnology research program with the University of Zimbabwe (UZ), and the Chinhoyi University of Technology (CUT).
Zimbabwean AIDS Activists March to National AIDS Council Demanding Accountability for AIDS Levy Funds
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)